Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Journal of the American Society of Nephrology : JASN|September 24, 2005
Ubiquitous and kidney-specific subunits of vacuolar H+-ATPase are differentially expressed during nephrogenesisFrançois Jouret, Céline Auzanneau, Huguette Debaix, et al.Oncoimmunology|June 28, 2012
Development of immune memory to glial brain tumors after tumor regression induced by immunotherapeutic Toll-like receptor 7/8 activationApostolis Stathopoulos, Chrystel Pretto, Laurent Devillers, et al.The Permanente Journal|March 19, 2015
Use of ERC-1671 Vaccine in a Patient with Recurrent Glioblastoma Multiforme after Progression during Bevacizumab Therapy: First Published ReportDaniela A Bota, Daniela Alexandru-Abrams, Chrystel Pretto, et al.Vaccine|April 14, 2015
First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivityVirgil E J C Schijns, Chrystel Pretto, Laurent Devillers, et al.Journal of Clinical & Cellular Immunology|June 24, 2014
Exploring the Therapeutic Efficacy of Glioma Vaccines Based on Allo- and Syngeneic Antigens and Distinct Immunological Costimulation ActivatorsApostolos Stathopoulos, Chrystel Pretto, Laurent Devillers, et al.CNS Oncology|August 31, 2018
Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4+ T-lymphocyte countsDaniela A Bota, Jinah Chung, Manisha Dandekar, et al.International Journal of Molecular Sciences|August 29, 2018
Therapeutic Immunization against GlioblastomaVirgil E J C Schijns, Chrystel Pretto, Anna M Strik, et al.Pageof 1